Article Text

Download PDFPDF
Management of hepatic haemangioma in pregnancy
  1. Anthony Spartan Casabianca1,
  2. Ana Ivette Hernandez Caballero2,
  3. Loralei L Thornburg3 and
  4. Darren Carpizo4
  1. 1General Surgery, University of Rochester, Rochester, New York, USA
  2. 2Pathology and Laboratory Medicine, University of Rochester, Rochester, New York, USA
  3. 3Obstetrics and Gynecology, University of Rochester, Rochester, New York, USA
  4. 4Surgical Oncology, University of Rochester Wilmot Cancer Institute, Rochester, New York, USA
  1. Correspondence to Dr Darren Carpizo; Darren_Carpizo{at}


Hepatic cavernous haemangioma is a benign tumour of vascular origin found within the liver. Often incidentally diagnosed, the management of these vascular masses is frequently determined by the size of the mass and symptoms associated with its compression of adjacent structures. Tumours >10 cm are known as giant haemangiomas and are associated with increased risks of compression symptoms, coagulopathies and haemorrhage. Known to express hormone receptors for oestrogen, intervention for these masses remains controversial in the setting of pregnancy where concerns for tumour growth and life-threatening complications are increased. Here we present the case of a woman in her 30s recently diagnosed with a giant haemangioma who is found to be pregnant, their management and a review of the literature.

  • Obstetrics and gynaecology
  • Gastrointestinal surgery
  • Surgical oncology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors ASC: conducted the background research and initial drafting of the manuscript with significant input and editorial guidance from DC and LLT. LLT and DC: consulted on the medical and surgical management of the patient, conducted the surgical procedures mentioned in the study and conceptualised the report. AIH provided pathology analysis and figure images. All four authors had full access to the data and reports at all times and have all seen and agreed upon the final draft for submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.